Literature DB >> 6160117

Suppressor factors: potential for immunotherapy.

R S Krakauer, J D Clough.   

Abstract

Mesh：

Substances：

Year:  1980        PMID： 6160117     DOI： 10.1016/0162-3109(80)90056-9

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN： 0162-3109


× No keyword cloud information.
  2 in total

1.  Studies on the mechanism of peptidoglycan- and lipopolysaccharide-induced polyclonal activation.

Authors:  R Dziarski
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

2.  Serum interferon in Navajo children with severe combined immunodeficiency disease inhibits lymphoblastogenesis.

Authors:  J F Jones; L M Minnich; D O Lucas; V A Fulginiti; Z Ingham; M P Langford; G J Stanton
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.